Are you saying the $600 million they owed just vanished?
If you have a drug with potential and you need money but that drug does not bring money now because you cannot get API, wouldn't you sell it?
I may be wrong - but just trying to look at opportunities. Nasrat did mention a few times ANDA's acquisitions - was he only thinking of the 3 ANDA's he bought back?
Market Data 
Markets 
AI
